Brief: Oncopeptides Complete First Sales Of Pepaxti In Greece
June 19 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES COMPLETE FIRST SALES OF PEPAXTI IN GREECE
* FIRST NAMED PATIENT SALES OF ITS FLAGSHIP DRUG PEPAXTI IN
GREECE
* SALES WERE MADE POSSIBLE THROUGH ONCOPEPTIDES' PARTNERSHIP
WITH
ARITI S.A
Source text for Eikon: ID:nMFN3ZjzcV
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy